Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 12 → 13·18:09, 19 Jul 2025
Difference between revision 12 and revision 13 of Xi'an Mokemei Biotechnology. 10 lines changed; the page grew by 1,307 bytes.
| Revision 12 — 23:05, 3 Jul 2025 BlankVialBo (talk) close an unbalanced quotation mark 7,201 bytes +144 | Revision 13 — 18:09, 19 Jul 2025 StubSorterBot (talk) bot: normalise citation format 8,508 bytes +1,307 | ||
|---|---|---|---|
| 52 | Submitted reports on MKM material to July 2026 cover the incretin range and a small number of repair peptides. Reported [[Area percent purity|area percent]] figures have been high across the set, and where an independent report and the accompanying certificate could be placed side by side the two have agreed within the range that different separations account for.{{r|reports}} | 52 | Submitted reports on MKM material to July 2026 cover the incretin range and a small number of repair peptides. Reported [[Area percent purity|area percent]] figures have been high across the set, and where an independent report and the accompanying certificate could be placed side by side the two have agreed within the range that different separations account for.{{r|reports}} |
| 53 | 53 | ||
| + | 54 | Where an independent report and a certificate differ slightly, the ordinary explanations are methodological: different columns, different integration parameters, different [[Reference standard|reference standards]], or sample handling between purchase and testing. None of them makes either figure wrong, and the difference across this set has stayed inside the range those explanations account for.{{r|reports}} A purchaser who wants the two figures to be comparable should ask for the gradient and column chemistry with the certificate, which are supplied against a named lot.{{r|usp1503}} | |
| + | 55 | ||
| + | 56 | == Ordering and availability == | |
| + | 57 | {{note|The organisation publishes its own catalogue and current stock at mokemeibiotechnology.com. [https://mokemeibiotechnology.com/ Visit MKM →]}} | |
| + | 58 | ||
| + | 59 | Catalogue lines dispatch from held stock. The catalogue includes standardised botanical extracts alongside synthetic peptides; the two are documented differently and a purchaser should know which they are ordering.{{r|reports}} | |
| + | 60 | ||
| + | 61 | Minimum order quantity is one vial for peptide lines. Extract listings carry their own minimum, stated on the listing. | |
| + | 62 | ||
| 54 | == References == | 63 | == References == |
| 55 | {{reflist}} | 64 | {{reflist}} |
| ⋮ | ⋮ | ||
| 58 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 67 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 59 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 68 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 69 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 60 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 70 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 61 | 71 |